Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Solid Tumors 1 Solid Tumor, Adult 1 PD-L1-selected Solid Tumors 1 Advanced Rare Malignant Solid Neoplasm 1

Interventions

Paclitaxel 15 atezolizumab 11 Gemcitabine 11 Carboplatin 9 pembrolizumab 8 Docetaxel 8 Bevacizumab 8 Irinotecan 7 Injections 6 Cetuximab 6 Capecitabine 6 Sunitinib 5 Leucovorin 5 Fluorouracil 5 Cyclophosphamide 5 tocilizumab 4 pazopanib 4 olaparib 4 navitoclax 4 liposomal doxorubicin 4 Topotecan 4 Oxaliplatin 4 Nivolumab 4 Erlotinib Hydrochloride 4 temsirolimus 3 spartalizumab 3 lenvatinib 3 fludarabine 3 cobimetinib 3 Cisplatin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Solid Tumors × Tiragolumab × Other solid neoplasm × Clear all

NCT06331598 2024-12-24

IMperator

Hoffmann-La Roche

Phase 2 Withdrawn

Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡